1. Home
  2. ESEA vs VYGR Comparison

ESEA vs VYGR Comparison

Compare ESEA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euroseas Ltd. (Marshall Islands)

ESEA

Euroseas Ltd. (Marshall Islands)

HOLD

Current Price

$56.53

Market Cap

432.9M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.39

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESEA
VYGR
Founded
2005
2013
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.9M
232.4M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
ESEA
VYGR
Price
$56.53
$4.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$62.00
$17.00
AVG Volume (30 Days)
39.6K
474.3K
Earning Date
11-18-2025
11-10-2025
Dividend Yield
5.08%
N/A
EPS Growth
6.77
N/A
EPS
17.38
N/A
Revenue
$223,794,428.00
$31,316,000.00
Revenue This Year
$10.05
N/A
Revenue Next Year
N/A
$71.78
P/E Ratio
$3.17
N/A
Revenue Growth
7.26
N/A
52 Week Low
$26.30
$2.65
52 Week High
$66.00
$6.55

Technical Indicators

Market Signals
Indicator
ESEA
VYGR
Relative Strength Index (RSI) 37.88 54.46
Support Level $58.05 $3.74
Resistance Level $63.99 $4.51
Average True Range (ATR) 2.09 0.21
MACD -0.52 0.06
Stochastic Oscillator 3.75 84.94

Price Performance

Historical Comparison
ESEA
VYGR

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: